Search

everythinglearnresearchcommunity

for

Search:↓

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Hairgain® significantly increased hair growth and was well-tolerated by individuals with hair loss.

The pandemic changed how often certain skin conditions were diagnosed.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

The study found that balding scalps have more thin hairs and larger oil glands, which might contribute to skin conditions related to hair loss.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Children's hair loss has many causes and requires careful diagnosis and personalized treatment, including emotional support.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Men can experience female pattern hair loss, needing different treatments.

New drug delivery systems improve treatment effectiveness and patient experience.

Ellis van Creveld syndrome, a rare genetic disorder, can cause unexpected abnormalities in various body organs, requiring thorough patient evaluations.

Hair loss link to COVID-19 severity likely due to other factors.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Hair loss patients may have different polyamine levels in various scalp areas.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Hair transplantation techniques have improved over time, leading to natural-looking results and high graft survival rates, making it a popular treatment for hair loss.

The lncRNA LOXL1-AS1 may help diagnose and treat androgenic alopecia.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.